Nyffenegger, N., Flace, A., Varol, A., Altermatt, P., Doucerain, C., Sundstrom, H., . . . Manolova, V. (2024). The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis. Wiley. https://doi.org/10.1002/hem3.147
Chicago-Zitierstil (17. Ausg.)Nyffenegger, Naja, Anna Flace, Ahmet Varol, Patrick Altermatt, Cédric Doucerain, Hanna Sundstrom, Franz Dürrenberger, und Vania Manolova. The Oral Ferroportin Inhibitor Vamifeport Prevents Liver Iron Overload in a Mouse Model of Hemochromatosis. Wiley, 2024. https://doi.org/10.1002/hem3.147.
MLA-Zitierstil (9. Ausg.)Nyffenegger, Naja, et al. The Oral Ferroportin Inhibitor Vamifeport Prevents Liver Iron Overload in a Mouse Model of Hemochromatosis. Wiley, 2024. https://doi.org/10.1002/hem3.147.